• Home
  • News
  • Analysis
  •  
    Regions
    • Australasia
    • Southeast Asia
    • Greater China
    • North Asia
    • South Asia
    • North America
    • Europe
    • Central Asia
    • MENA
  •  
    Funds
    • LPs
    • Buyout
    • Growth
    • Venture
    • Renminbi
    • Secondary
    • Credit/Special Situations
    • Infrastructure
    • Real Estate
  •  
    Investments
    • Buyout
    • Growth
    • Early stage
    • PIPE
    • Credit
  •  
    Exits
    • IPO
    • Open market
    • Trade sale
    • Buyback
  •  
    Sectors
    • Consumer
    • Financials
    • Healthcare
    • Industrials
    • Infrastructure
    • Media
    • Technology
    • Real Estate
  • Events
  • Chinese edition
  • Data & Research
  • Weekly Digest
  • Newsletters
  • Sign in
  • Events
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)870 240 8859

      Email: customerservices@incisivemedia.com

      • Sign in
     
      • Saved articles
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • RSS
    • Twitter
    • LinkedIn
    • Newsletters
  • Free Trial
  • Subscribe
  • Weekly Digest
  • Chinese edition
  • Data & Research
    • Latest Data & Research
      2023-china-216x305
      Regional Reports

      The reports review the year's local private equity and venture capital activity and are filled with up-to-date data and intelligence on fundraising, investments, exits and M&A. The regional reports also feature information on key companies.

      Read more
      2016-pevc-cover
      Industry Review

      Asian Private Equity and Venture Capital Review provides an independent overview of the private equity, venture capital and M&A activities in the Asia region. It delivers insights on investments made, capital raised, sector specific figures and more.

      Read more
      AVCJ Database

      AVCJ Database is the ultimate link between Asian dealmakers and those who provide advisory, financial, legal and technological services to the private equity, venture capital and M&A industries. It is packed with facts and figures on more than 153,000 companies and almost 117,000 transactions.

      Read more
AVCJ
AVCJ
  • Home
  • News
  • Analysis
  • Regions
  • Funds
  • Investments
  • Exits
  • Sectors
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)870 240 8859

    Email: customerservices@incisivemedia.com

    • Sign in
 
    • Saved articles
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 

Healthcare

pills-drugs-pharma-3
PE-owned Japanese drug maker seeks bankruptcy protection

Kyowa Pharmaceutical Industry, a Japanese generic drug manufacturer owned by Unison Capital, has applied for alternative dispute resolution, an out-of-court process that allows companies to continue operations while negotiating with creditors on a restructuring.

  • North Asia
  • 07 August 2023
ai-drug-pharma-pill
PE-backed Adlai Nortye pursues US listing

Adlai Nortye, a private equity-backed Chinese cancer drug developer that previously filed to list in Hong Kong, is now targeting an IPO in the US.

  • Greater China
  • 02 August 2023
polymer
Deal focus: Topolefin finds favour as import substitution play

China-based Topolefin has gained traction thanks to breakthroughs in polymer science and the willingness of local medical equipment makers to use its components in foreign-dominated supply chains

  • Greater China
  • 02 August 2023
catheter-medical-healthcare
Longreach sells Hong Kong medical devices player to Boyu

The Longreach Group has sold Quasar Medical, a Hong Kong-headquartered medical devices manufacturer it has owned since 2019, to Boyu Capital for an undisclosed sum.

  • Greater China
  • 01 August 2023
biotech-lab-healthcare-pharma-03
Singapore's Mirxes raises $50m, files for Hong Kong IPO

Singapore-based biotech player Mirxes has raised USD 50m in Series D funding - at a post-money valuation of USD 600m - from the likes of Beijing-based Fupu Capital and Japan's Mitsui & Co, and filed to list in Hong Kong.

  • Southeast Asia
  • 31 July 2023
telehealth-telemedicine-healthcare-technology-doctor
Astra leads Series D for Indonesia health-tech player Halodoc

Indonesia-based healthcare technology platform Halodoc has completed its Series D round with USD 100m in commitments. It comes more than two years after the company raised USD 80m in Series C funding.

  • Southeast Asia
  • 31 July 2023
syringe-needle-healthcare
Hong Kong's Immuno Cure raises $27m

Hong Kong’s Immuno Cure BioTech, a vaccine and antibodies developer focused on cancers, inflammatory and infectious diseases, has raised USD 27m in Series A funding featuring Gobi Partners.

  • Greater China
  • 28 July 2023
india-baby
BPEA EQT buys India fertility clinic business

BPEA EQT has agreed to acquire a controlling stake in Indira IVF, India’s largest fertility clinic chain, facilitating an exit for minority investor TA Associates.

  • South Asia
  • 28 July 2023
india-pharma-lab-drug-healthcare
China’s VectorBuilder becomes unicorn, files for Shanghai IPO

China-based gene delivery technology player VectorBuilder has topped up its Series C round - achieving unicorn status in the process - and filed for an IPO on Shanghai’s Star Market.

  • Greater China
  • 27 July 2023
dollar-money-bills-notes-stack-01
Mirae Asset PE arm seeks $200m for Fund II

Maps Capital, a private equity investment arm of Mirae Asset Financial Group, has launched its second US dollar-denominated fund with a target of USD 200m.

  • Greater China
  • 24 July 2023
laser-medical-surgery
Hahn acquires Korea medical devices player

Hahn & Company has acquired a nearly two-thirds stake in Korea-listed medical laser maker Lutronic through a tender offer for about KRW 629bn (USD 497m).

  • North Asia
  • 19 July 2023
hospital-operation-surgery-healthcare-04
China’s Cornerstone Robotics raises $112m

China-based Cornerstone Robotics, a surgical robots specialist, has raised a CNY 800m (USD 112m) round featuring BridgeOne Capital and Lenovo Capital & Incubator Group.

  • Greater China
  • 17 July 2023
biotech-lab-healthcare-pharma-01
Legend Capital leads Series A for China CDMO CoJourney

China and US-based contract development and manufacturing organisation (CDMO) CoJourney has raised a Series A of USD 30m led by Legend Capital.

  • Greater China
  • 13 July 2023
optician-ophthalmology-eye-test-02
Quadria to invest $155m in India eye hospital

Quadria Capital has invested USD 155m in Maxivision Eye Hospital, a chain of 42 eye hospitals and vision clinics across five states in southern and western India.

  • South Asia
  • 13 July 2023
fv-hospital
Quadria to exit Vietnam's FV Hospital via $381m trade sale

Quadria Capital is set to exit Vietnam’s FV Hospital after a strategic buyer agreed to a USD 381.4m acquisition touted as the largest ever healthcare transaction in Vietnam.

  • Southeast Asia
  • 12 July 2023
india-pharma-lab-drug-healthcare
Portfolio: True North and Integrace

True North has spent five years transforming Integrace from a low-margin drug portfolio into a broader, better-performing platform with digital capabilities. The M&A story isn’t finished yet

  • South Asia
  • 11 July 2023
biotech-lab-healthcare-pharma-03
SDIC leads $97m Series A for China's Pyrotech Therapeutics

China-based Pyrotech Therapeutics, which develops treatments for inflammation and tumours, has raised a Series A of CNY 700m (USD 97m) led by state-owned investor SDIC Venture Capital.

  • Greater China
  • 11 July 2023
billy-cho-bio-photo
Healthcare specialist CBC adds managing director

Asia healthcare investor CBC Group has appointed Billy Cho, formerly CFO of listed Chinese drug developer Zai Lab, as a senior managing director for private equity.

  • Greater China
  • 11 July 2023
hospital-operation-surgery-healthcare-equipment
PE-backed Lu Daopei Medical files for Hong Kong IPO

Lu Daopei Medical Group Holding, which runs a network of hospitals in China that specialise in the treatment of blood diseases, has filed for a Hong Kong IPO.

  • Greater China
  • 10 July 2023
biotech-lab-healthcare-pharma-01
Carlyle-backed Adicon trades up after $52m Hong Kong IPO

Adicon Holdings, a China-based independent clinical laboratory (ICL) services provider backed by The Carlyle Group, gained 12% on debut following a HKD 408.9m (USD 52.2m) Hong Kong IPO.

  • Greater China
  • 03 July 2023
biotech-lab-healthcare-pharma-03
Singapore T-cell therapist gets China government funding

Singaporean T-cell immunotherapy company Lion TCR has raised USD 40m in its second tranche of Series B funding. Guangzhou Industrial Investment and Capital Operation Holding Group led the round.

  • Greater China
  • 28 June 2023
healthcare-stethoscope
Proparco makes $35m LP commitment to Quadria healthcare fund – update

French development finance institution (DFI) Proparco has made a USD 35m fund commitment to Singapore’s Quadria Capital, a healthcare-focused GP active across South and Southeast Asia.

  • South Asia
  • 14 June 2023
telehealth-telemedicine-healthcare-technology
Australia's Wesfarmers buys VC-backed Instascripts for $91m

InstantScripts, an Australia-based telehealth business backed by listed VC firm Bailador Technology Investments, has agreed to be acquired by Wesfarmers for approximately AUD 135m (USD 91m).

  • Australasia
  • 13 June 2023
india-map-globe
India's Lok seeks $200m for Fund IV, gets AIIB support

Indian impact investor Lok Capital has secured USD 25m from Asian Infrastructure Investment Bank (AIIB) for its fourth private equity fund. The target is USD 200m.

  • South Asia
  • 12 June 2023
2 3 4
  • About AVCJ
  • Advertise
  • Contacts
  • About ION Analytics
  • Terms of use
  • Privacy policy
  • Group disclaimer
  • RSS
  • Twitter
  • LinkedIn
  • Newsletters

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013